Japanese Insurance Stock News

Board meeting puts Mitsubishi Materials’ financing plans in focus Mitsubishi Materials (TSE:5711) has called a board meeting for 8 July 2026 to review issuing zero coupon convertible bonds maturing in 2030 and 2032, a financing step that could matter for shareholders. See our latest analysis for Mitsubishi Materials. The board meeting takes place at a time when Mitsubishi Materials’ share price has been under pressure in recent months, with a 7 day share price return of down 10.27% and a 90...

GMO Payment Gateway, Inc. has issued its 3rd unsecured straight bond in Japan, raising ¥10 billion via three-year notes paying a 2.286% annual coupon, with proceeds earmarked for investment, lending, and working capital. An A- rating from Rating and Investment Information, Inc. underpins this financing move, signaling lender confidence in the company’s credit profile and its capacity to support ongoing digital payments expansion. We will now examine how this ¥10 billion bond issuance, and...

ROHM (TSE:6963) has drawn fresh attention after ROHM Semiconductor introduced its new 600V Super Junction MOSFET series, R60xxXNx and R60xxWNx, designed to support higher efficiency and more compact power supplies for data centers and industrial equipment. See our latest analysis for ROHM. The product launch comes as ROHM’s share price has climbed strongly this year, with a 90 day share price return of 53.38% and a year to date share price return of 145.88%. The 1 year total shareholder...

Pfizer and Astellas Pharma recently announced that the U.S. FDA approved PADCEV (enfortumab vedotin-ejfv) plus Keytruda as both neoadjuvant and adjuvant treatment for adult patients with muscle-invasive bladder cancer, regardless of cisplatin eligibility, based on positive Phase 3 EV-304 trial data versus standard gemcitabine-cisplatin chemotherapy. This marks the first platinum-free regimen approved for all muscle-invasive bladder cancer patients, materially expanding the clinical and...

DENSO stock: why a battery passport trial matters for investors DENSO (TSE:6902) is in focus after working with TÜV Rheinland Japan and AESC Group on a battery passport validation that aligns with EU Battery Regulation requirements for energy storage systems. The project used real data from AESC's energy storage business and confirmed that DENSO's battery passport service can support traceability, data security and regulatory compliance for products headed to Europe. See our latest analysis...

ABC-MartInc (TSE:2670) drew investor attention after reporting June 2026 sales, with all stores and existing stores both showing a 6.6% decline compared with growth just over 6% a year earlier. See our latest analysis for ABC-MartInc. At a share price of ¥2,620.5, ABC-MartInc has seen its short term momentum soften, with the 7 day share price return down 6.41% and the 30 day share price return down 4.81%, while the 5 year total shareholder return of 46.43% points to a stronger longer term...

The record US$26.5b Nasdaq listing of SK Hynix has put AI semiconductor stocks firmly back in the spotlight, with investors watching how fresh capital for high bandwidth memory and AI chip production might ripple through the sector. With bookbuilding reportedly 7x oversubscribed and expectations that the new ADR could influence how similar businesses are valued, this news is hard to ignore if you follow AI hardware. Below, you will see 3 stocks from our AI Semiconductor Stocks screener that...

CKD (TSE:6407) is in focus after disclosing that a former accounting staff member at subsidiary CKD GLOBAL SERVICE CORP. was arrested for embezzling ¥178 million, which was fully booked in the latest fiscal year. See our latest analysis for CKD. Despite the embezzlement headline, CKD’s recent 30 day share price return of 16.8% and year to date share price return of 127.72% indicate strong momentum. The 1 year total shareholder return of 184.55% highlights how reinvested dividends have added...

Cooling inflation in several major economies, mixed but resilient growth signals, and central banks stressing data dependence have pushed many investors toward companies with solid balance sheets and disciplined use of capital. In this setting, stocks that combine high return on equity, a history of sound execution, and robust financial foundations can offer a cleaner way to gain exposure without relying heavily on momentum or aggressive forecasts. This article focuses on our Solid Balance...

Valor Holdings (TSE:9956) has set out a multi pronged plan that includes a capital and business alliance with KOHNAN SHOJI, a stock split, amended articles of incorporation, and a follow on equity offering. See our latest analysis for Valor Holdings. Valor Holdings' share price has eased in recent months, with a 30 day share price return of 9.42% and a 90 day return of 16.15% in decline. However, the 1 year total shareholder return of 28% and 3 year total shareholder return of 76.49% point to...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Nihon Dengi Co., Ltd. ( TSE:1723 ), might not be a large cap stock, but it saw significant share price movement during...

Takara (TSE:7921) has wrapped up FY 2026 with fourth quarter revenue of ¥8.8 billion and basic EPS of ¥131.69, capping a year in which trailing twelve month revenue was ¥31.2 billion and EPS reached ¥261.92. Over recent quarters, revenue has ranged from ¥6.3 billion to ¥9.1 billion, while quarterly EPS has moved between ¥11.48 and ¥182.98, giving investors a clear view of how earnings power has shifted across the year. With a current net margin of 10.9% versus 13.7% a year earlier, the focus...

Chiyoda stock has returned 109.5% over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiple checks still point to the shares trading below what the fundamentals imply. Over the last 12 months, Chiyoda has delivered a 109.5% share price return, which puts more focus on whether there is still valuation headroom after such a strong run. Expectations for future cash flows can support the current pricing, while any setback in converting projects...

Rigaku Corporation recently opened the Rigaku Solutions Center Osaka at its Osaka Plant, creating a centralized hub with a new cleanroom to deliver hands-on training for field service engineers who support semiconductor metrology systems. By standardizing service practices and expanding advanced, practical training for engineers and distribution partners worldwide, the facility meaningfully deepens Rigaku’s support infrastructure for semiconductor industry customers. We’ll now examine how...

In early July 2026, Kasumigaseki Capital Co., Ltd. issued consolidated earnings guidance for the fiscal year ending August 31, 2026, forecasting net sales of ¥150,000 million, operating profit of ¥26,500 million, profit attributable to owners of parent of ¥16,500 million, and basic earnings per share of ¥672.42. At the same July 3, 2026 board meeting, the company also considered changes to its shareholder benefit program, signaling potential adjustments to how returns are structured for...

Takeda Pharmaceutical (TSE:4502) has drawn fresh investor attention after agreeing to work with Insilico Medicine’s Pharma.AI platform, which ties its drug discovery pipeline more closely to artificial intelligence based molecule design. See our latest analysis for Takeda Pharmaceutical. The Pharma.AI collaboration lands at a time when Takeda Pharmaceutical’s share price has risen 8.5% year to date, while its 1-year total shareholder return of 26.82% points to solid long-term momentum,...

ROHM Semiconductor recently launched a new lineup of 600V Super Junction MOSFETs, the R60xxXNx and PrestoMOS R60xxWNx series, now in mass production and aimed at high-efficiency, space-saving power supplies for AI servers, data centers, and industrial equipment. The addition of compact DFN8080-5L and TOLL surface-mount packages with common footprints could make ROHM’s devices easier drop-in options for power designers seeking multi-sourcing flexibility and improved thermal performance. We’ll...

Sharp (TSE:6753) is drawing new attention after launching its first health-focused smartwatch, the Karada Mate Watch. The device uses HEALBE’s FLOW technology to automatically estimate calorie intake, hydration, and other physiological metrics. See our latest analysis for Sharp. Despite the Karada Mate Watch signalling a new push into digital health wearables, Sharp’s share price return tells a mixed story, with the stock down 18.75% year to date and up 6.9% over 90 days, while the 1 year...

Japan’s consumer goods and retail giants are sitting at the crossroads of two powerful forces: potential policy shifts from the Bank of Japan and global demand tied to AI and electronics. With rates holding at 1% for now and inflation pressures still on the BOJ’s radar, pricing power, cost control, and exposure to import costs all matter more for Japanese Consumer Goods and Retail stocks. This article explains how that backdrop connects to our screener and highlights 3 stocks that appear...

Ajinomoto Co., Inc. and the University of Tokyo recently reported that their jointly developed ANPS-Day system can assess a full day’s diet quality using biomarkers from healthy Japanese adults, marking a Japan-first link between real-world dietary data and 24-hour urine collection results. This scientific validation strengthens Ajinomoto’s position in health-oriented food technologies, potentially enhancing the credibility and differentiation of its nutrition-focused products and...

In July 2026, Custom Market Insights published a report projecting the global lithium-ion battery market to reach about US$468.50 billion by 2035, with Panasonic Holdings highlighted among the key industry participants benefiting from government-backed energy storage and electric vehicle demand. The report also points to Asia Pacific’s current leadership and very large expected growth in North America, underscoring how regional policy support could be especially important for manufacturers...

Nippon Shinyaku (TSE:4516) has drawn fresh investor attention after announcing an option agreement for EXG-7001, an mRNA based Duchenne muscular dystrophy therapy that could broaden its rare disease pipeline if development progresses. See our latest analysis for Nippon Shinyaku. Nippon Shinyaku’s latest EXG-7001 option agreement comes after a tough spell for the stock, with the share price down 21.06% over 90 days and 26.51% year to date, yet still delivering a 30.18% total shareholder return...

In recent weeks, global markets have shown mixed performances, with major U.S. indices like the Nasdaq Composite and S&P 500 advancing, while small-cap focused indices such as the Russell 2000 have seen declines amid a cooling labor market and subdued consumer confidence. As investors navigate these complex conditions, identifying promising small-cap stocks requires focusing on companies that demonstrate resilience through strong fundamentals and potential for growth in niche markets.